Sunday, April 11, 2021
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

by Global Biodefense Staff
November 25, 2020
Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

Credit: Shutterstock

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate or commercialize for development of a therapeutic or a diagnostic for norovirus infections.

The available technology relates to chimpanzee-human chimeric monoclonal antibodies that specifically bind to norovirus and have therapeutic potential. The antibodies that were tested in a primate model of infection have shown protection against norovirus and may have application as immunoprophylaxis to protect individuals from infections or as a possible treatment for infected individuals, or to be used to develop a diagnostic for detection of norovirus infections.

Read more about this exciting collaboration opportunity: https://lnkd.in/effyMEB or contact Peter Soukas, J.D., 301-496-2644; peter.soukas@nih.gov

Tags: Editor PickNIAIDNorovirusRapid DiagnosticsTech Transfer

Related Posts

New Initiative to Support Studies of the Bat Immune System
Funding News

New Initiative to Support Studies of the Bat Immune System

April 7, 2021
Texas Biomed Scientists Partner with DoD to Test SARS-CoV-2 Decontamination Technologies
Decontamination

Texas Biomed Scientists Partner with DoD to Test SARS-CoV-2 Decontamination Technologies

March 11, 2021
DARPA Grant to Texas Tech Funds Development of Indoor Airborne Virus Sensor
Biodetection

DARPA Grant to Texas Tech Funds Development of Indoor Airborne Virus Sensor

March 10, 2021
Medical Countermeasure Development
Funding News

2021 BAA for Development of Medical Countermeasures for Biological Threats

March 2, 2021
Load More

Latest News

A Virologist Explains Their Concerns About Coronavirus Variants

A Virologist Explains Their Concerns About Coronavirus Variants

April 8, 2021
What is Thrombocytopenia, the Rare Condition Possibly Linked to the AstraZeneca Vaccine?

What is Thrombocytopenia, the Rare Condition Possibly Linked to the AstraZeneca Vaccine?

April 8, 2021
New Initiative to Support Studies of the Bat Immune System

New Initiative to Support Studies of the Bat Immune System

April 7, 2021
National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder

National Vaccine Trial Will Focus on Those with History of Severe Allergies or Mast Cell Disorder

April 7, 2021

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2021 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Events
  • Subscribe

© 2021 Stemar Media Group LLC